India, Nov. 12 -- Pentixapharm Holding AG (PTP.DE) said it entered into an agreement with Eckert & Ziegler SE (EUZ.DE), its sole bondholder, to extend its €18.5 million convertible bond to December 31, 2030, from December 31, 2027.
The agreement postpones repayment of €5 million already drawn by three years and allows Pentixapharm to access the remaining €13.5 million until June 30, 2030.
In exchange, the annual interest rate will rise to 6% from 4%, effective January 1, 2027. Pentixapharm also gains the right to repay the bond early at its principal amount plus accrued interest. Conversion rights may generally be exercised throughout the term.
Pentixapharm also agreed that any security granted for other bonds or compar...